First National Bank Of Mount Dora, Trust Investment Services Acelrx Pharmaceuticals Inc Transaction History

First National Bank Of Mount Dora, Trust Investment Services

  • $396 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 08, 2019
SELL
$2.1 - $3.93 $42,000 - $78,600
-20,000 Closed
0 $0
Q1 2019

Apr 02, 2019
BUY
$2.35 - $3.83 $47,000 - $76,600
20,000 New
20,000 $70,000

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track First National Bank Of Mount Dora, Trust Investment Services Portfolio

Follow First National Bank Of Mount Dora, Trust Investment Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Mount Dora, Trust Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Mount Dora, Trust Investment Services with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email